At Real Chemistry, making the world a healthier place isn’t just an aspiration—it’s our everyday reality. Our drive to transform healthcare is informed by our blend of deep scientific expertise, human-centred creativity, and AI-driven insights, fostering a unique environment where innovation thrives and our people are impact-obsessed. As a global agency, we provide a full suite of services across healthcare communications and marketing to our clients, including top players in the pharmaceutical and biotech industries.

Our #LifeatRealChem culture is rooted in our people—we believe we are best together and are committed to excellence for both our clients and colleagues. Whether you're a seasoned professional or just starting your career, if you share our passion for healthcare and connection, we invite you to explore our opportunities.

Discover your purpose. Embrace innovation. Experience #LifeatRealChem.

Senior Strategist

21GRAMS | Strategy | London

Job Summary

Real Chemistry is looking for a Senior Strategist to join the growing 21GRAMS Strategy team in London. This is an opportunity to support high-profile global accounts within one of healthcare advertising’s most creative agencies, working alongside award-winning creative, strategy and client teams.

You will combine strong research and analytical foundations with creative strategic thinking. You will explore markets, audiences and competitors, turn insights into clear strategic recommendations, and help shape work that resonates with clients and their audiences. The role will mainly support senior strategists while offering strong scope to learn, collaborate internationally and progress as the team continues to grow.

What you’ll do

Conduct primary and desk research to build a clear understanding of markets, sectors, audiences and behaviours.

Develop consumer and stakeholder insights that help shape creative and brand strategy.

Carry out category and competitor analysis, identifying the most relevant opportunities and challenges.

Support senior strategy colleagues across global account work, strategic projects and client deliverables.

Contribute to creative briefs, strategic narratives and presentations, making complex findings clear and engaging.

Work closely with Creative, Client Services, Medical Education and wider cross-functional teams.

Support new business pitches through research, insight development and strategic thinking.

Present thinking confidently to internal teams and, as experience grows, to clients.

Manage multiple priorities and deadlines in a fast-moving agency environment.

This position is a perfect fit for you if

You are curious, creative and commercially aware, with a genuine interest in understanding people and what drives them.

You are a clear and engaging communicator who enjoys presenting ideas and contributing to discussion.

You bring positive energy, ambition and a desire to develop within strategy.

You can balance detailed research with the ability to step back, identify the key insight and tell a compelling story.

You are collaborative, proactive and comfortable working across different disciplines and with colleagues in other markets.

You are adaptable, organised and able to deliver high-quality work against deadlines.

Our Company values - Best Together, Impact-Obsessed, Excellence Expected, Evolve Always and Accountability with an “I” - really speak to you.

What you should have

Approximately 3-5 years of strategy, planning, research or insight experience within an agency environment.

Experience in healthcare advertising is welcome, but candidates from traditional consumer or AOR advertising agencies who are interested in moving into healthcare will also be considered.

A strong foundation in market research, desk research, audience insight and competitor or category analysis.

Experience working across more than one client, category, sector or therapy area.

An understanding of how agency teams operate, including fast-paced delivery and changing priorities.

Experience supporting new business pitches is useful but not essential.

Strong storytelling and presentation skills, with the ability to distil information into clear, persuasive recommendations.

A collaborative mindset and the potential to grow into greater strategic ownership over time.

Real Chemistry is proud to be Great Place to Work® certified; check out what our people shared about our culture and workplace on our Great Places to Work Profile here.

We believe we can do our best when feeling our best, which is why we’ve put together a benefits program designed to give you the support you and your family need at every stage of life. Real Chemistry offers a comprehensive benefit program and perks, tailored to your region. Globally, this includes offices in our key markets with free snacks to keep you running all day long, generous holiday and paid time off, options for private medical, dental, and vison plans, and support in saving for the future. Other perks include mental wellness coaching and support and access to more than 13,000 online classes with LinkedIn Learning. Learn more about our great benefits and perks and search specific offerings in your region at: www.realchemistrybenefits.com.

At Real Chemistry, we believe we're at our best when we're connected. Our Real Hybrid and Regional Teams (Real HART) approach is designed to foster collaboration, learning, innovation, and meaningful relationships while providing flexibility where appropriate. Because our workforce spans multiple countries, regions, and client needs, work arrangements may vary by role and location. Some positions offer hybrid or remote flexibility, while others require regular in-office presence. For example, certain teams and regions, including some of our UK operations, have office-based requirements. Your recruiter will discuss the specific expectations for the role you're pursuing during the interview process and keep you informed throughout the hiring journey. For employees located within a one-hour commute of a Real Chemistry office, we require in-person attendance two days per week, either from a Real Chemistry office or when working onsite with clients. Employees in regions without a nearby office may work remotely and come together throughout the year for collaboration, culture-building, learning, and team connection opportunities. While these guidelines reflect our current workplace model, we understand that everyone’s circumstances are unique. If you require additional flexibility, we welcome an open conversation with your recruiter and our HR team to discuss your needs and determine what may be possible.

Real Chemistry is an Equal Opportunity employer. We continually strive to build and sustain an inclusive and equitable work environment where our employees feel empowered to leverage all they bring from their personal lived experience and professional expertise, to make our team the best in the industry. We encourage motivated and qualified applicants to apply without regard to race, color, religion, sex (including pregnancy), sexual orientation, gender identity/expression, ethnic or national origin, age, physical or mental disability, genetic information, marital information, or any other characteristic protected by federal, state, or local employment discrimination laws where Real Chemistry operates. Should you require accommodations throughout the interview process please let your recruiter know.

*Notice: Real Chemistry and its affiliates' names are being misused by scammers through messaging services, fake websites, and apps. Do not share personal or financial information or make payments to any unverified sources claiming to be connected to Real Chemistry. We are working to stop these unauthorized activities and protect our community. Read more here.

About the company

Real Chemistry helps healthcare brands grow by creating AI-powered, customer-centered healthcare experiences. It combines AI-enabled experiences with cross-disciplinary teams to design and deliver programs across patient, provider, and payer touchpoints. The company differentiates itself through large, integrated teams of specialists focused exclusively on healthcare and customer experience under one mission. Its goal is to transform how healthcare is experienced while driving commercial success for healthcare organizations.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

San Francisco, California

Founded

2001

Get referred to Real Chemistry

See people who can refer or advise you

Simplify's Take

What believers are saying

MaestroHCP launched October 1, 2026, with pilot engagement up 57% versus traditional approaches.
Spurwing acquisition on July 6, 2026 expanded Real Chemistry's APAC footprint immediately.
Board additions Frank Clyburn and Chris Fikry strengthen commercialization and data credibility in 2026.

What critics are saying

New Mountain Capital ownership pressures exits if AI products miss revenue targets by 2027.
Law360 lists Real Chemistry TTAB cases, including Balchem Corporation filed August 4, 2026.
AI commoditization squeezes agency margins when Pfizer, Novartis, and peers internalize orchestration.

What makes Real Chemistry unique

Real Chemistry combines healthcare AI, media, communications, and medical expertise across one stack.
MaestroHCP turns HCP engagement into closed-loop orchestration, using 600 signals per physician.
APAC hub in Singapore and Germany leadership deepen local execution for multinational pharma.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Unlimited Paid Time Off
Wellness Program
Mental Health Support
Paid Vacation

Company News

Business Wire

Oct 1st, 2026

Real Chemistry launches MaestroHCP AI platform for pharmaceutical HCP marketing with 57% higher engagement rates

Real Chemistry has launched MaestroHCP, an AI-powered omnichannel orchestration platform designed for pharmaceutical marketers to plan, activate and measure healthcare professional (HCP) engagement. The enterprise-level platform integrates audience intelligence, approved content, channel requirements and performance data in one workflow. MaestroHCP enables individual-level, next-best-action activation using AI models to recommend optimal messaging, channels and timing for each HCP. The platform also provides closed-loop measurement, investment decisioning and adaptive intelligence capabilities. In an early pilot deployment, MaestroHCP demonstrated engagement rate increases of up to 57% compared with traditional approaches, with signs of up to 2.5 times greater product adoption of additional approved indications. Developed in collaboration with Amazon Web Services, the platform uses tools such as Amazon SageMaker to analyse over 600 signals from each HCP. Real Chemistry is a commercialisation partner serving healthcare and life sciences companies.

Yahoo Finance

Oct 1st, 2026

Real Chemistry launches MaestroHCP, an ai-powered platform for HCP omnichannel marketing.

Real Chemistry launches MaestroHCP, an ai-powered platform for HCP omnichannel marketing. Business Wire Enterprise platform helps pharmaceutical marketers plan, activate and measure omnichannel engagement with greater speed, precision and control NEW YORK, October 01, 2026-(BUSINESS WIRE)-Real Chemistry, a leader in AI-driven insights and marketing and communications exclusively for the healthcare and life sciences sectors, today announced the launch of MaestroHCP, the first enterprise-level omnichannel orchestration platform designed to help pharmaceutical marketers plan, activate and measure HCP engagement with more speed, precision and control. The platform brings together audience intelligence, approved content, channel requirements and performance data in one workflow, helping marketers move more efficiently from insight to compliant execution. Built to meet the unique demands of pharmaceutical marketing, MaestroHCP connects real-time personalization, next-best-action deployment, investment decisioning and closed-loop measurement across all active channels, enabling more precise engagement and optimization at the HCP level. For marketing teams, MaestroHCP provides a clearer way to identify eligible audiences, select messages and channels, and measure performance within the industry rules and guardrails. "For years, marketers have invested in data, intelligence and sophisticated engagement strategies, yet the last mile between insight and execution has remained stubbornly manual, fragmented and difficult to scale," said Elizabeth Beringer, President, Real Chemistry Media. "With MaestroHCP, we are unifying decisioning, orchestration and activation so marketers can deliver more relevant experiences to HCPs with greater transparency and control. The future of marketing is smarter orchestration, and MaestroHCP was made for it." The platform is designed to address four core execution challenges: * HCP-level journey design: MaestroHCP enables individual-level, next-best-action activation by using AI models and engagement signals to recommend the right message, channel and timing for each HCP. * Closed-loop measurement and optimization: MaestroHCP surfaces conversions and optimization opportunities so marketing teams can refine engagement strategies and act on performance insights faster. * Investment decisioning: Rather than relying on fixed brand- or segment-level investment strategies, MaestroHCP uses performance, engagement and spend data across tactics to optimize channel mix and budget decisions at the individual HCP level. * Adaptive intelligence over time: MaestroHCP uses audience and campaign data to continuously improve decisioning and omnichannel orchestration.

Provoke Media

Sep 15th, 2026

PRovoke Media names 15 Global Agency of the Year honorees.

PRovoke Media names 15 Global Agency of the Year honorees. The 15 firms will be presented with their awards during the Global SABRE Awards ceremony in Chicago on Monday, October 26. One will be named the Best PR Agency in the World for 2026. Paul Holmes 15 Sep 2026 // 8:02AM GMT CHICAGO - Fifteen of the top performing agencies from around the world will receive Global Agency of the Year awards at this year's PRovoke Media Global Summit in Chicago. The trophies will be presented during the Global SABRE Awards ceremony on Monday, October 26. The 15 winners were selected from among 75 agencies that received Agency of the Year trophies in North America, EMEA, the Asia-Pacific and Latin America - and more than 300 profiled by this publication over the past year - as part of PRovoke research that identifies the World's Best Public Relations Agencies. The Global SABRE Awards ceremony in Chicago will celebrate the best from across the entire world of public relations: the 40 best campaigns from around the world will receive our Global SABRE Awards - with a countdown from number 40 to the number one campaign. And one of the 15 Agency of the Year winners will be named as PRovoke Media's Best Agency in the World. The 15 winners are: * Adfactors PR - the leading PR agency in South Asia, noted for both growth and impressive work in the corporate and financial communications sector; * Bully Pulpit International - an Agency of the Year winner in the UK, but recognized in as a premier public affairs specialist in the US and Europe also; * Brands2Life - the UK technology specialist has been a thought leader, and demonstrated strong growth last year in a challenging market; * Edelman - it was a tough financial year for the world's largest public relations agency, but the creative work eared for Global SABREs and it was an Agency of the Year in both Asia and the Middle East; * FGS Global - one of our US Agencies of the Year turned in strong financial performance and also topped the global M&A rankings, handling more high-stakes special situations than any other firm; * Fight or Flight - still smaller than most firms on this list, the B2B specialist punches above it weight and won Agency of the Year honors in both the UK and the US; * Golin - last year's Best Agency in the World is on the list again, a recognition of continued creative excellence and growth in excess of any of its publicly-owned peers; * Hopscotch - an Agency of the Year winner in both continental Europe and Asia, the French agency excels in experiential but has solidified its PR credentials too; * Mad Hat Asia - one of our Asia Agency of the Year winners after a strong year, the South East Asian network is now part of fast-growing Vero; * MSL - a winner in North America and in continental Europe, largely on the back of stellar creative work in both regions; * Real Chemistry - our overall North American Agency of the Year and a winner in Asia, the digitally-driven, healthcare focused firm is now one of the world's top five PR agencies; * Rud Pedersen - based in the Nordics, the corporate and public affairs specialist has built a formidable European network and was one of our European honorees for the second consecutive year; * Ruder Finn - our overall Asia-Pacific Agency of the Year was also awarded in North America, for strong financial performance and thought leadership in AI and beyond; * The Romans - the UK-based creative boutique is now a significant force in the Middle East and developing its US and European presence; * Whyte - the Brussels-based corporate affairs firm was one of our European Agencies of the Year, growing organically and by acquisition and establishing itself as a significant force in new markets. The firms represent a cross-section of the industry, from large publicly-traded multination's to independent boutiques, from North America to Europe to Asia, and from healthcare to consumer marketing to corporate and public affairs - but all outperformed their peers over the past year. Article tags News direct to your inbox The agency playbook. The PR industry's most comprehensive listing of firms from every region and specialty.

Real Chemistry

Aug 25th, 2026

Real Chemistry deepens German market expertise with appointment of Dirk Poschenrieder as Managing Director, Germany.

Real Chemistry deepens German market expertise with appointment of Dirk Poschenrieder as Managing Director, Germany. August 25, 2026 Senior hire strengthens Real Chemistry's ability to help healthcare clients connect global strategy to nuanced needs for in-market execution LONDON, August 25, 2006 - Real Chemistry, a global leader in AI- and insights-driven healthcare communications, has announced the appointment of Dirk Poschenrieder as Managing Director, Germany, strengthening the company's ability to support healthcare clients in one of Europe's most important and nuanced life sciences markets. The appointment reflects Real Chemistry's continued investment in helping clients navigate the distinct launch, reimbursement, regulatory and stakeholder dynamics of the German healthcare landscape. "As Europe's largest pharmaceutical market, Germany plays a critical role in the success of our clients' regional and global strategies," said Suzanne Jacobs, Head of International Markets at Real Chemistry. "Our clients need partners with integrated global capabilities who understand the nuances of the local market and can connect those insights across regions for improved outcomes. Dirk brings exactly that combination of strategic leadership, commercial expertise and deep understanding of the German healthcare landscape." In his new role, Poschenrieder will lead Real Chemistry's growth and client delivery in Germany, partnering with clients to ensure business, communications and engagement strategies are grounded in local expertise while leveraging connections to Real Chemistry's global network and integrated capabilities. Poschenrieder brings 25 years' experience across healthcare marketing, communications and business development. He joins Real Chemistry after serving as Managing Director of Publicis Health Germany. His experience also includes eight years as Managing Director at Havas Health Network in Germany and client-side roles at Johnson & Johnson Innovative Medicine, Sony and Deutsche Post DHL. "What attracted me to Real Chemistry is the company's uniquely integrated approach to solving client challenges," said Dirk Poschenrieder, Managing Director, Germany at Real Chemistry. "In today's environment, healthcare and life sciences organizations need partners who can bring together the right expertise across communications and marketing, insights and analytics, and technology and AI to address increasingly complex business needs. Real Chemistry's model enables exceptional teams to organize themselves around client challenges, instead of operational silos, and I'm excited to work alongside our talented colleagues to help clients succeed in Germany and across Europe." Poschenrieder's appointment marks the latest step in Real Chemistry's global growth strategy, following the company's recent acquisition of Singapore-based Spurwing Communications, establishing its first Asia Pacific strategic hub. About Real Chemistry: 25 Years of Future-Focused Healthcare Celebrating its 25th anniversary this year, Real Chemistry is a tier-one commercialization partner to the world's most innovative life sciences and healthcare companies. As a leading provider of AI-powered audience analytics and insights, Real Chemistry helps the healthcare industry better understand, reach and engage critical audiences to improve the healthcare experience for all. Anchored by a culture of innovation and creativity, Real Chemistry's 2,400+ global experts across life sciences, marketing communications and technology are singularly focused on navigating the complexities of bringing scientific advances to market - and to the people who need them most. Real Chemistry's brand portfolio includes 21GRAMS, a highly awarded creative agency, and starpower, a celebrity and influencer practice. Today, Real Chemistry operates through offices across North America, Europe, the Middle East and Asia Pacific, complemented by a strategic partner network in Latin America and Africa - enabling the company to support clients wherever they operate.

Bermuda Re+ILS

Jul 30th, 2026

mea Platform appoints Robin Tolla as chief human resources officer.

mea Platform appoints Robin Tolla as chief human resources officer. mea Platform has appointed Robin Tolla (pictured) as chief human resources officer, with the former Axa XL human resources executive joining the insurance-focused artificial intelligence company to lead its global people strategy as it continues to expand across Europe, Asia and the Americas. Tolla brings more than 30 years of human resources leadership experience, including more than 15 years in the insurance and technology sectors. Her expertise spans people strategy, organisational design and merger and acquisition integration. Her appointment follows a period of rapid recruitment at mea, with the company adding employees across engineering, product, client delivery and client solutions. The company said Tolla will help support its continued growth and product development. Before joining mea, Tolla was co-chief people officer at healthcare communications and technology company Real Chemistry. Earlier, she spent seven years at XL Group, later Axa XL, where she held a series of senior HR leadership roles, including vice president of HR supporting the chief operating officer of the combined XL Catlin business. During her tenure, she led HR integration work across major acquisitions and helped design operating models for the Axa XL integration. Martin Henley, chief executive officer of mea, said: "Throughout her career in the insurance and technology industries, Robin has designed operating models and led M&A integrations inside the exact environments we now serve. Time and time again, she has showcased her ability to build organisations that absorb fast growth and turn it into business performance. That insurance pedigree, combined with her operational discipline, is precisely what mea needs at this stage." Tolla said: "The best insurance operators have always known that people are what make the difference, and that has not changed with AI; it has only raised the stakes. mea has built technology that owns the repeatable work and elevates talented people to the decisions that matter. Shaping the culture and organisation behind the company reimagining insurance operations is something I am honoured to be a part of." Editor's picks. Re/insurance 12 June 2026 Re/insurance 5 June 2026 Re/insurance 5 June 2026 Re/insurance 4 June 2026 Re/insurance 1 June 2026 Re/insurance 29 May 2026